Breast cancer drug fulvestrant appears more effective in the presence of CK8 and CK18

Monday, March 15, 2010 - 09:14 in Health & Medicine

Women's responsiveness to the second-line breast cancer drug fulvestrant may depend on whether the cancer cells are expressing two key proteins, Indiana University Bloomington scientists report in this month's Cancer Biology and Therapy...

Read the whole article on

More from

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net